Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast Cancer
Open Access
- 15 October 2005
- journal article
- clinical trial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (20) , 7434-7443
- https://doi.org/10.1158/1078-0432.ccr-04-0548
Abstract
Purpose: This study was designed to identify genes that could predict response to doxorubicin-based primary chemotherapy in breast cancer patients.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Feature selection algorithms to find strong genesPattern Recognition Letters, 2005
- Gene expression arrays in cancer research: methods and applicationsCritical Reviews in Oncology/Hematology, 2005
- Changes in Gene Expression Associated With Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2005
- Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression ProfilingJournal of Clinical Oncology, 2005
- Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to ChemotherapyCancer Research, 2004
- Strong Feature Sets from Small SamplesJournal of Computational Biology, 2002
- Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistanceOncogene, 2001
- A Novel Gene, CRR9, Which Was Up-Regulated in CDDP-Resistant Ovarian Tumor Cell Line, Was Associated with ApoptosisBiochemical and Biophysical Research Communications, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sortingDifferentiation, 1991